2024-01-01 2024-12-31 2024-12-31 false 13004015 LINK HEALTH GROUP LIMITED 2025-12-30 false iso4217:GBP xbrli:pure 13004015 2023-12-31 13004015 2024-12-31 13004015 2024-01-01 2024-12-31 13004015 2022-12-31 13004015 2023-12-31 13004015 2023-01-01 2023-12-31 13004015 bus:SmallEntities 2024-01-01 2024-12-31 13004015 bus:AuditExempt-NoAccountantsReport 2024-01-01 2024-12-31 13004015 bus:FullAccounts 2024-01-01 2024-12-31 13004015 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 13004015 core:WithinOneYear 2024-12-31 13004015 core:AfterOneYear 2024-12-31 13004015 core:WithinOneYear 2023-12-31 13004015 core:AfterOneYear 2023-12-31 13004015 core:ShareCapital 2024-12-31 13004015 core:SharePremium 2024-12-31 13004015 core:RevaluationReserve 2024-12-31 13004015 core:OtherReservesSubtotal 2024-12-31 13004015 core:RetainedEarningsAccumulatedLosses 2024-12-31 13004015 core:ShareCapital 2023-12-31 13004015 core:SharePremium 2023-12-31 13004015 core:RevaluationReserve 2023-12-31 13004015 core:OtherReservesSubtotal 2023-12-31 13004015 core:RetainedEarningsAccumulatedLosses 2023-12-31 13004015 core:LandBuildings 2024-12-31 13004015 core:PlantMachinery 2024-12-31 13004015 core:Vehicles 2024-12-31 13004015 core:FurnitureFittings 2024-12-31 13004015 core:OfficeEquipment 2024-12-31 13004015 core:NetGoodwill 2024-12-31 13004015 core:IntangibleAssetsOtherThanGoodwill 2024-12-31 13004015 core:ListedExchangeTraded 2024-12-31 13004015 core:UnlistedNon-exchangeTraded 2024-12-31 13004015 core:LandBuildings 2023-12-31 13004015 core:PlantMachinery 2023-12-31 13004015 core:Vehicles 2023-12-31 13004015 core:FurnitureFittings 2023-12-31 13004015 core:OfficeEquipment 2023-12-31 13004015 core:NetGoodwill 2023-12-31 13004015 core:IntangibleAssetsOtherThanGoodwill 2023-12-31 13004015 core:ListedExchangeTraded 2023-12-31 13004015 core:UnlistedNon-exchangeTraded 2023-12-31 13004015 core:LandBuildings 2024-01-01 2024-12-31 13004015 core:PlantMachinery 2024-01-01 2024-12-31 13004015 core:Vehicles 2024-01-01 2024-12-31 13004015 core:FurnitureFittings 2024-01-01 2024-12-31 13004015 core:OfficeEquipment 2024-01-01 2024-12-31 13004015 core:NetGoodwill 2024-01-01 2024-12-31 13004015 core:IntangibleAssetsOtherThanGoodwill 2024-01-01 2024-12-31 13004015 core:ListedExchangeTraded 2024-01-01 2024-12-31 13004015 core:UnlistedNon-exchangeTraded 2024-01-01 2024-12-31 13004015 core:MoreThanFiveYears 2024-01-01 2024-12-31 13004015 core:Non-currentFinancialInstruments 2024-12-31 13004015 core:Non-currentFinancialInstruments 2023-12-31 13004015 dpl:CostSales 2024-01-01 2024-12-31 13004015 dpl:DistributionCosts 2024-01-01 2024-12-31 13004015 core:LandBuildings 2024-01-01 2024-12-31 13004015 core:PlantMachinery 2024-01-01 2024-12-31 13004015 core:Vehicles 2024-01-01 2024-12-31 13004015 core:FurnitureFittings 2024-01-01 2024-12-31 13004015 core:OfficeEquipment 2024-01-01 2024-12-31 13004015 dpl:AdministrativeExpenses 2024-01-01 2024-12-31 13004015 core:NetGoodwill 2024-01-01 2024-12-31 13004015 core:IntangibleAssetsOtherThanGoodwill 2024-01-01 2024-12-31 13004015 dpl:GroupUndertakings 2024-01-01 2024-12-31 13004015 dpl:ParticipatingInterests 2024-01-01 2024-12-31 13004015 dpl:GroupUndertakings core:ListedExchangeTraded 2024-01-01 2024-12-31 13004015 core:ListedExchangeTraded 2024-01-01 2024-12-31 13004015 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2024-01-01 2024-12-31 13004015 core:UnlistedNon-exchangeTraded 2024-01-01 2024-12-31 13004015 dpl:CostSales 2023-01-01 2023-12-31 13004015 dpl:DistributionCosts 2023-01-01 2023-12-31 13004015 core:LandBuildings 2023-01-01 2023-12-31 13004015 core:PlantMachinery 2023-01-01 2023-12-31 13004015 core:Vehicles 2023-01-01 2023-12-31 13004015 core:FurnitureFittings 2023-01-01 2023-12-31 13004015 core:OfficeEquipment 2023-01-01 2023-12-31 13004015 dpl:AdministrativeExpenses 2023-01-01 2023-12-31 13004015 core:NetGoodwill 2023-01-01 2023-12-31 13004015 core:IntangibleAssetsOtherThanGoodwill 2023-01-01 2023-12-31 13004015 dpl:GroupUndertakings 2023-01-01 2023-12-31 13004015 dpl:ParticipatingInterests 2023-01-01 2023-12-31 13004015 dpl:GroupUndertakings core:ListedExchangeTraded 2023-01-01 2023-12-31 13004015 core:ListedExchangeTraded 2023-01-01 2023-12-31 13004015 dpl:GroupUndertakings core:UnlistedNon-exchangeTraded 2023-01-01 2023-12-31 13004015 core:UnlistedNon-exchangeTraded 2023-01-01 2023-12-31 13004015 core:NetGoodwill 2024-12-31 13004015 core:IntangibleAssetsOtherThanGoodwill 2024-12-31 13004015 core:LandBuildings 2024-12-31 13004015 core:PlantMachinery 2024-12-31 13004015 core:Vehicles 2024-12-31 13004015 core:FurnitureFittings 2024-12-31 13004015 core:OfficeEquipment 2024-12-31 13004015 core:AfterOneYear 2024-12-31 13004015 core:WithinOneYear 2024-12-31 13004015 core:ListedExchangeTraded 2024-12-31 13004015 core:UnlistedNon-exchangeTraded 2024-12-31 13004015 core:ShareCapital 2024-12-31 13004015 core:SharePremium 2024-12-31 13004015 core:RevaluationReserve 2024-12-31 13004015 core:OtherReservesSubtotal 2024-12-31 13004015 core:RetainedEarningsAccumulatedLosses 2024-12-31 13004015 core:NetGoodwill 2023-12-31 13004015 core:IntangibleAssetsOtherThanGoodwill 2023-12-31 13004015 core:LandBuildings 2023-12-31 13004015 core:PlantMachinery 2023-12-31 13004015 core:Vehicles 2023-12-31 13004015 core:FurnitureFittings 2023-12-31 13004015 core:OfficeEquipment 2023-12-31 13004015 core:AfterOneYear 2023-12-31 13004015 core:WithinOneYear 2023-12-31 13004015 core:ListedExchangeTraded 2023-12-31 13004015 core:UnlistedNon-exchangeTraded 2023-12-31 13004015 core:ShareCapital 2023-12-31 13004015 core:SharePremium 2023-12-31 13004015 core:RevaluationReserve 2023-12-31 13004015 core:OtherReservesSubtotal 2023-12-31 13004015 core:RetainedEarningsAccumulatedLosses 2023-12-31 13004015 core:NetGoodwill 2022-12-31 13004015 core:IntangibleAssetsOtherThanGoodwill 2022-12-31 13004015 core:LandBuildings 2022-12-31 13004015 core:PlantMachinery 2022-12-31 13004015 core:Vehicles 2022-12-31 13004015 core:FurnitureFittings 2022-12-31 13004015 core:OfficeEquipment 2022-12-31 13004015 core:AfterOneYear 2022-12-31 13004015 core:WithinOneYear 2022-12-31 13004015 core:ListedExchangeTraded 2022-12-31 13004015 core:UnlistedNon-exchangeTraded 2022-12-31 13004015 core:ShareCapital 2022-12-31 13004015 core:SharePremium 2022-12-31 13004015 core:RevaluationReserve 2022-12-31 13004015 core:OtherReservesSubtotal 2022-12-31 13004015 core:RetainedEarningsAccumulatedLosses 2022-12-31 13004015 core:AfterOneYear 2024-01-01 2024-12-31 13004015 core:WithinOneYear 2024-01-01 2024-12-31 13004015 core:Non-currentFinancialInstruments core:CostValuation 2024-01-01 2024-12-31 13004015 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2024-01-01 2024-12-31 13004015 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2024-01-01 2024-12-31 13004015 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2024-01-01 2024-12-31 13004015 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2024-01-01 2024-12-31 13004015 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2024-01-01 2024-12-31 13004015 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2024-01-01 2024-12-31 13004015 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2024-01-01 2024-12-31 13004015 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2024-01-01 2024-12-31 13004015 core:Non-currentFinancialInstruments core:CostValuation 2024-12-31 13004015 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2024-12-31 13004015 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2024-12-31 13004015 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2024-12-31 13004015 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2024-12-31 13004015 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2024-12-31 13004015 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2024-12-31 13004015 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2024-12-31 13004015 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2024-12-31 13004015 core:Non-currentFinancialInstruments core:CostValuation 2023-12-31 13004015 core:Non-currentFinancialInstruments core:AdditionsToInvestments 2023-12-31 13004015 core:Non-currentFinancialInstruments core:RevaluationsIncreaseDecreaseInInvestments 2023-12-31 13004015 core:Non-currentFinancialInstruments core:DisposalsDecreaseInInvestments 2023-12-31 13004015 core:Non-currentFinancialInstruments core:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments 2023-12-31 13004015 core:Non-currentFinancialInstruments core:ImpairmentLossReversalProvisionsForImpairmentInvestments 2023-12-31 13004015 core:Non-currentFinancialInstruments core:AcquisitionsIncreaseInProvisionsForImpairmentInvestments 2023-12-31 13004015 core:Non-currentFinancialInstruments core:DisposalsDecreaseInProvisionsForImpairmentInvestments 2023-12-31 13004015 core:Non-currentFinancialInstruments core:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments 2023-12-31 13004015 bus:Director1 2024-01-01 2024-12-31

LINK HEALTH GROUP LIMITED

Registered Number
13004015
(England and Wales)

Unaudited Financial Statements for the Year ended
31 December 2024

LINK HEALTH GROUP LIMITED
Company Information
for the year from 1 January 2024 to 31 December 2024

Director | GIBBS, Daniel

Registered Address | 20 Market Sreet
| Altrincham
| WA14 1PF

Registered Number | 13004015 (England and Wales)

LINK HEALTH GROUP LIMITED
Statement of Financial Position
31 December 2024

| Notes | 2024 |  | 2023
--- | --- | --- | --- | ---
|  | £ |  | £ |  | £ |  | £
Fixed assets |  |  |  |  |  |  |  |
Tangible assets | 3 |  |  | 1,591 |  |  |  | 6,743
|  |  |  | 1,591 |  |  |  | 6,743
Current assets |  |  |  |  |  |  |  |
Debtors | 4 | 179,187 |  |  |  | 209,638 |  |
Cash at bank and on hand |  | 9,869 |  |  |  | 100,331 |  |
|  | 189,056 |  |  |  | 309,969 |  |
Creditors amounts falling due within one year | 5 | (180,127) |  |  |  | (298,126) |  |
Net current assets (liabilities) |  |  |  | 8,929 |  |  |  | 11,843
Total assets less current liabilities |  |  |  | 10,520 |  |  |  | 18,586
Net assets |  |  |  | 10,520 |  |  |  | 18,586
Capital and reserves |  |  |  |  |  |  |  |
Called up share capital |  |  |  | 100 |  |  |  | 100
Profit and loss account |  |  |  | 10,420 |  |  |  | 18,486
Shareholders' funds |  |  |  | 10,520 |  |  |  | 18,586

- The company was entitled to exemption from audit for this reporting period under section 477 of the Companies Act 2006 relating to small companies.
- The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
- The Director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
- These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.
- The directors have chosen to not file a copy of the company’s profit and loss account under section 444 (5A) Companies Act 2006.

The financial statements were approved and authorised for issue by the Director on 30 December 2025, and are signed on its behalf by:
GIBBS, Daniel Director Registered Company No. 13004015

LINK HEALTH GROUP LIMITED
Notes to the Financial Statements
for the year ended 31 December 2024

1. | Accounting policies
--- | ---

| Statutory information
--- | ---
| The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

| Statement of compliance
--- | ---
| The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.

| Basis of preparation
--- | ---
| The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).

| Functional and presentation currency
--- | ---
| The financial statements are presented in sterling and this is the functional currency of the company.

| Turnover policy
--- | ---
| Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover consists of revenue earned from rendering of services.

| Revenue from sale of goods
--- | ---
| Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.

| Employee benefits
--- | ---
| Contributions to defined contribution plans are expensed in the period to which they relate.

| Foreign currency translation
--- | ---
| Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.

| Current taxation
--- | ---
| Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.

| Tangible fixed assets and depreciation
--- | ---
| Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

|  | Straight line (years)
| Office Equipment | 3

2. | Average number of employees
--- | ---

|  | 2024 |  | 2023
| Average number of employees during the year | 25 |  | 26

3. | Tangible fixed assets
--- | ---

|  | Office Equipment |  | Total
--- | --- | --- | --- | ---
|  | £ |  | £
| Cost or valuation
| At 01 January 24 | 15,984 |  | 15,984
| At 31 December 24 | 15,984 |  | 15,984
| Depreciation and impairment
| At 01 January 24 | 9,241 |  | 9,241
| Charge for year | 5,152 |  | 5,152
| At 31 December 24 | 14,393 |  | 14,393
| Net book value
| At 31 December 24 | 1,591 |  | 1,591
| At 31 December 23 | 6,743 |  | 6,743

4. | Debtors: amounts due within one year
--- | ---

|  | 2024 |  | 2023
--- | --- | --- | --- | ---
|  | £ |  | £
| Amounts owed by group undertakings | 156,173 |  | 198,653
| Other debtors | 20,247 |  | 6,955
| Prepayments and accrued income | 2,767 |  | 4,030
| Total | 179,187 |  | 209,638

5. | Creditors: amounts due within one year
--- | ---

|  | 2024 |  | 2023
--- | --- | --- | --- | ---
|  | £ |  | £
| Trade creditors / trade payables | 42,036 |  | 28,923
| Bank borrowings and overdrafts | 2,720 |  | -
| Taxation and social security | 122,959 |  | 255,951
| Accrued liabilities and deferred income | 12,412 |  | 13,252
| Total | 180,127 |  | 298,126

6. | Related party transactions
--- | ---
| During the year the company had the following transactions with companies in which the directors have a material interest. Brought forward: £198,653 Amount advanced: £2,230,217 Amount repaid: £2,272,697 Carried forward: £156,173 The loan above was repayable on demand and unsecured.